In his doping confessional to CBS's 60 Minutes, Tyler Hamilton not only tells of witnessing teammate Lance Armstrong's use of the banned blood-boosting agent EPO when they rode together on the U.S. Postal Service team from 1995 to 2001, but he also delivers a blow to Armstrong's longtime defense against such allegations: "Never a failed test," Armstrong tweeted in response to Hamilton's remarks. "I rest my case."
Hamilton paints a picture of a testing cover-up at the 2001 Tour de Suisse, telling CBS that Armstrong told him that he failed a drug test there. The UCI, cycling's governing body, has denied there was any such cover-up, but another former teammate, Floyd Landis, made a similar allegation last year in letters to USA Cycling as federal officials began investigating whether Armstrong was involved in a doping operation while the team was receiving sponsorship money from the Postal Service. Armstrong has repeatedly denied ever taking a performance-enhancing drug, much less testing positive for one. But if the Tour de Suisse accusations prove true, it would underscore what many in cycling have asked for two decades: Was Armstrong too big to fail?